1. Home
  2. EDSA vs GIGM Comparison

EDSA vs GIGM Comparison

Compare EDSA & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • GIGM
  • Stock Information
  • Founded
  • EDSA 2015
  • GIGM 1998
  • Country
  • EDSA Canada
  • GIGM Taiwan
  • Employees
  • EDSA N/A
  • GIGM N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • GIGM Computer Software: Programming Data Processing
  • Sector
  • EDSA Health Care
  • GIGM Technology
  • Exchange
  • EDSA Nasdaq
  • GIGM Nasdaq
  • Market Cap
  • EDSA 6.0M
  • GIGM 16.0M
  • IPO Year
  • EDSA N/A
  • GIGM 2000
  • Fundamental
  • Price
  • EDSA $1.68
  • GIGM $1.55
  • Analyst Decision
  • EDSA Strong Buy
  • GIGM
  • Analyst Count
  • EDSA 1
  • GIGM 0
  • Target Price
  • EDSA $21.00
  • GIGM N/A
  • AVG Volume (30 Days)
  • EDSA 31.5K
  • GIGM 13.4K
  • Earning Date
  • EDSA 12-13-2024
  • GIGM 10-30-2024
  • Dividend Yield
  • EDSA N/A
  • GIGM N/A
  • EPS Growth
  • EDSA N/A
  • GIGM N/A
  • EPS
  • EDSA N/A
  • GIGM N/A
  • Revenue
  • EDSA N/A
  • GIGM $3,085,000.00
  • Revenue This Year
  • EDSA N/A
  • GIGM N/A
  • Revenue Next Year
  • EDSA N/A
  • GIGM N/A
  • P/E Ratio
  • EDSA N/A
  • GIGM N/A
  • Revenue Growth
  • EDSA N/A
  • GIGM N/A
  • 52 Week Low
  • EDSA $1.55
  • GIGM $1.23
  • 52 Week High
  • EDSA $5.99
  • GIGM $1.58
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 35.86
  • GIGM 66.42
  • Support Level
  • EDSA $1.55
  • GIGM $1.45
  • Resistance Level
  • EDSA $1.91
  • GIGM $1.60
  • Average True Range (ATR)
  • EDSA 0.14
  • GIGM 0.03
  • MACD
  • EDSA 0.04
  • GIGM 0.01
  • Stochastic Oscillator
  • EDSA 49.07
  • GIGM 72.06

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About GIGM GigaMedia Limited

GigaMedia Ltd is a publisher of online games. It has only one reportable segment, Digital Entertainment service. Digital Entertainment service business operates a portfolio of online games, mainly targeting online game players across Europe, and Asia, including Greater China and Southeast Asia. The company's portfolio of online games includes predominantly PC-based, non-cash gambling, or casino casual games, including MahJong and various card and table games. The company's product lines include MahJong, AkaSeka, Yume 100, Fun Vegas, and others. The company operates in Taiwan and Hong Kong.

Share on Social Networks: